文献速递慢病防控与筛查免疫规划卫生政策与健康促进

韩国急性冠脉综合征患者接种流感疫苗的成本效果

Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea.
PubMed 文献 · Vaccine · 2017-04-17

本研究基于2013年韩国健康保险审查评价院国家患者样本数据库,构建概率模型估算682258例急性冠脉综合征(ACS)患者主要不良心血管事件(MACE)的直接与间接成本,并结合既往系统综述与Meta分析中流感疫苗对MACE发生率的效果,评估接种流感疫苗的成本效果。敏感性分析中多数估计值位于优势区域。结论认为ACS患者接种流感疫苗具有高度成本效果,推荐用于减轻ACS相关的临床和社会经济负担。

要点

  • ACS患者接种流感疫苗每年可预防16514例MACE相关住院和2764例过早死亡。
  • 作者结论认为ACS患者接种流感疫苗具有高度成本效果并推荐接种。

核心结论

  • ACS患者接种流感疫苗在降低MACE相关住院和过早死亡成本方面具有高度成本效果。
  • 作者推荐将流感疫苗接种作为减轻ACS相关临床和社会经济负担的手段。

研究设计与样本

  • 基于2013年韩国健康保险审查评价院(HIRA)国家患者样本(NPS)数据库的概率模型研究,纳入682258例ACS患者。
  • 流感疫苗对ACS患者MACE发生率的效果取自既往系统综述与Meta分析。

主要发现

  • 模型估算流感疫苗接种每年可预防16514例MACE相关住院和2764例过早死亡。
  • 敏感性分析显示多数估计值位于优势区域。

关键数值与推荐

  • 流感疫苗接种每年预防16514例MACE相关住院和2764例过早死亡。

临床怎么用

  • 作者结论认为ACS患者接种流感疫苗具有高度成本效果,并推荐接种以减轻ACS相关临床和社会经济负担。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Influenza can cause cardiovascular abnormalities by inappropriately activating the coagulation cascade. Therefore, influenza vaccination is important because it decreases the risk of hospitalization for and mortality associated with heart disease. In particular, it reduces the occurrence of major adverse cardiovascular events (MACEs) in acute coronary syndrome (ACS) patients. Our study aimed to estimate the disease burden of MACEs and its related direct and indirect costs in ACS patients. METHODS: We estimated the direct and indirect cost of MACEs in ACS patients using a probabilistic model and the Health Insurance Review and Assessment (HIRA)-National Patient Sample (NPS) database. The effect of the influenza vaccination on the rate of MACE in ACS patients was determined using a previous systematic review and meta-analysis. RESULTS: Our study included 682,258 ACS patients obtained from the 2013 NPS database. According to our model, influenza vaccination would prevent 16,514 MACE-related hospitalizations and 2764 premature deaths in Korea per year. The overall reduction in costs would be $86.2 million per year from a societal perspective. Based on the results of sensitivity analysis, most of the estimated values were in the dominant area. CONCLUSIONS: Our findings show that influenza vaccination in ACS patients is highly cost effective in terms of lowering the cost of hospitalization and premature death due to MACE. Therefore, influenza vaccination is recommended as a means of relieving the clinical and socioeconomic burdens associated with ACS.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Suh J, Kim B, Yang Y, et al. Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea. Vaccine. 2017. PMID: 28427844. doi:10.1016/j.vaccine.2017.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。